1Holmes J,Stanko J,Varchenko M,et al.Comparative neurotoxieity of oxaliplatin,cisplatin,and ormaplatin in a wistar ratmodel[J].Toxicol Sci,1998,46:342-351.
2Verrelle P,Meissonnier F,Fonck Y,et al.Clinical relevance of immunohistochemical detection of multidrug resistance p-glycoprotein in breast caicinoma[J].Natl Cancer Inst,1991,83:111.
3Chan HS,Haddad G,Thomer PS,et al.p-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma[J].N Engl J Med,1991,325:1608.
4Panella TJ,Smith DG,Schold SG,et al.Modulation of o6alkylguanine-DNA alkvltransferase-mediated carmustine resistance using streptozotocin:a phase I trial.Cancer Res,1992,52:2456.
7Gamelin L,Boisdron Cellel M,Delva R,et al.A retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouncil and leucovorin for advanced cobrectal cancer[J].Clin Cancer Res,2004,10(25):4055-4061.
